PAK1 and Patent ductus arteriosus: The inhibition of PAK1 blocks the PSC-mediated immune evasion of pancreatic ductal adenocarcinoma (PDA) cells, while reducing the intrinsic and PSC-stimulated PD-L1 expression in PDA cells, which further sensitizes PDA cells to CD8+ T cells [56].